Brief Description
ReRx is developing novel oral therapeutics to treat patients with severe metabolic diseases including obesity, metabolic syndrome, diabetes, and liver diseases. The company's therapeutics target metabolic pathways involved in regulating energy homeostasis and improve treatment outcomes compared to similar pharmacological agents.
Timeline
- 2023. Company founded
Inventors
Chi Zhu, Anders Michael Naar, Justin Yu-Sun Lee